Business

CCM Research Issues Initial Report on BIOREM INC.

CCM Research Issues Initial Report on BIOREM INC.

articleBiorem Inc.February 2, 20093/company/biorem-inc/news/ccm-research-issues-initial-report-on-biorem-inc
CCM Research Issues Initial Report on BIOREM INC.

About this update from Biorem Inc.

[{"type":"text","content":"CCM Research Issues Initial Report on BIOREM INC.\n\n\n\nCCM Research Issues Initial Report on BIOREM INC.\n\nCCM Research analyst, Walt Spaude, CFA, has written an initiating report on Biorem Inc.\n\nToronto, Ontario CANADA, February 02, 2009 /FSC/ - Biorem Inc. (BRM - TSX Venture), \nBIOREM(r)manufactures Biosorbens(r) biofilter media and is a leading supplier of biofilters and biotrickling for air pollution control in municipal and industrial applications, including BIOCUBE(r) modular units and Mytilus(r) biotrickling filters. With over 600 installed systems and over a decade of experience, the Company's products are the technology of choice for odor control at wastewater treatment plants across North America. Additional information on BIOREM(r) is also available at www.biorem.biz. \n\nIn the report the analyst states, \"Biorem Inc. is executing on a well thought out strategy resulting in significant top line growth, an increasing installed base, and in its most recent quarter, a net profit.\"\n\nThe analyst continues, \"Fiscal stimulus will substantially increase in the near term as governments attempt to increase aggregate demand and reduce unemployment in light of the ongoing global recession. Coupled with low interest rates and greater liquidity in the financial markets, infrastructure spending is expected to ramp up. This will be especially true in Biorem's large U.S. market, where the new incoming administration has pledged significant increased spending on infrastructure projects with an emphasis on \"green\" initiatives.\"\n\nRegarding growth, the analyst notes: \"Top line growth will result in a substantial increase in earnings and share price over time as fixed costs are allocated over a larger revenue base. Recent results suggest that a top line ramp up may be beginning. Revenue for the first nine months of 2008 was C$9.8 M compared to C$6.5 M during the same period in 2007....\"\n\nA free copy of the report can be found at:\nhttp://www.ccmopportunitybase.com/news/files/files13628/BRM_Initial%20Report%20February%201,%202008.pdf \n\n\nCCM Research is a division of Cronus Capital Markets, Inc.  Cronus Capital Markets, Inc., through its CCM Corporate Advisory division, entered into a one year C$55,000.00 contract with the Company to assist it with the creation and execution of information-based strategies to...

More updates from Biorem Inc.